CBDN Stock Overview
CBD Global Sciences Inc. engages in the production and sale of industrial hemp derived cannabidiol infused consumable and topical products in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
CBD Global Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.045 |
| 52 Week High | CA$0.36 |
| 52 Week Low | CA$0.03 |
| Beta | 0.56 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -85.48% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -85.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBDN | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 0% | -6.6% | 0.7% |
| 1Y | -85.5% | 41.0% | 4.9% |
Return vs Industry: CBDN underperformed the Canadian Pharmaceuticals industry which returned -29.5% over the past year.
Return vs Market: CBDN underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| CBDN volatility | |
|---|---|
| CBDN Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 13.8% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in CA Market | 18.1% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: CBDN has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CBDN's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | n/a | Brad Wyatt | www.cbdglobalsciences.com |
CBD Global Sciences Inc. engages in cannabidiol (CBD) farming, processing, and product manufacturing business. It offers biomass, CBD oil, and CBD oil products under the Aethics, CannaOil, and Strasburg Pharms brand names. The company was incorporated in 2018 and is headquartered in Lakewood, Colorado.
CBD Global Sciences Inc. Fundamentals Summary
| CBDN fundamental statistics | |
|---|---|
| Market cap | CA$2.23m |
| Earnings (TTM) | -CA$6.20m |
| Revenue (TTM) | CA$494.24k |
4.5x
P/S Ratio-0.4x
P/E RatioIs CBDN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBDN income statement (TTM) | |
|---|---|
| Revenue | US$361.15k |
| Cost of Revenue | US$181.59k |
| Gross Profit | US$179.56k |
| Other Expenses | US$4.71m |
| Earnings | -US$4.53m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.092 |
| Gross Margin | 49.72% |
| Net Profit Margin | -1,253.65% |
| Debt/Equity Ratio | -103.1% |
How did CBDN perform over the long term?
See historical performance and comparison